Psyco Quality of Life and Procreation BRCA1/2 (QoL)
Women With BRCA1/2 Mutation: Guilt Feelings and Impact on Procreation Decision
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Anita Caruso
- Phone Number: +39 06 52665332
- Email: anita.caruso@ifo.it
Study Locations
-
-
-
Rome, Italy, 00144
- Recruiting
- "Regina Elena" National Cancer Institute
-
Varese, Italy, 21100
- Recruiting
- Università dell'Insubria
-
Contact:
- Marco Bellani
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Women with BRCA1/2 mutation affected or not by breast neoplasm
- Women with BRCA1/2 mutation affected or not by breast neoplasm and with at least a son/daughter
- Women with at list middle school diploma
- Women available to do interviews
Exclusion Criteria:
- Women with other oncological pathology
- Women with cognitive deficient and/or inability to comply to the requirements of the study
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of feeling guilting
Time Frame: 24 monts
|
|
24 monts
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RS1702/22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.